Metabolic / GLP-1
Adipotide
A peptidomimetic that homes to prohibitin receptors on white-adipocyte vasculature and triggers localised apoptosis; investigated only in preclinical primate models.
Also known as: FTPP, Prohibitin-TP01
Quick facts
Molecular weight
1,393 Da
Half-life
6 h
Frequency
daily
Admins / wk
7
Routes
SubQ
Typical dose
100 mcg–500 mcg
Mechanism & positioning
A peptidomimetic that homes to prohibitin receptors on white-adipocyte vasculature and triggers localised apoptosis; investigated only in preclinical primate models.
Researched for: white-adipocyte vascular targeting, pro-apoptotic adipose reduction (preclinical).
Reconstitution defaults
Default vial
5 mg
BAC water
2 mL
Concentration
2500 mcg/mL
Doses per vial
~50
Calculate with this peptide
References
- Barnhart KF et al., Sci Transl Med, 2011.
Related peptides in the Metabolic / GLP-1 class
Semaglutide
A long-acting GLP-1 receptor agonist researched for its role in glucose-dependent insulin secretion and reduced gastric emptying.
Tirzepatide
A dual GIP and GLP-1 receptor agonist investigated for superior weight and glycaemic outcomes versus selective GLP-1 agonists.
Retatrutide
A triple agonist of GIP, GLP-1, and glucagon receptors currently in late-phase research for obesity and metabolic indications.
AOD-9604
A fragment of the C-terminus of human GH researched for stimulating lipolysis without affecting blood glucose or IGF-1.
SLU-PP-332
A small-molecule pan-ERR agonist investigated in preclinical models for inducing exercise-mimetic mitochondrial gene expression in muscle and adipose tissue.
5-Amino-1MQ
A small-molecule selective NNMT inhibitor investigated in preclinical models for reducing methyl-group sequestration in adipose tissue and restoring NAD+/SAM balance.